Psoriasis News and Research

Latest Psoriasis News and Research

Data from Provectus' PV-10 pre-clinical study on melanoma to be presented at AACR meeting

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces that data on PV-10 will be presented in a poster presentation at the American Association for Cancer Research Annual Meeting in Washington, DC.

23 Jan 2013

Hope for premature babies with neurologic disabilities

Damage caused by cerebral ischemia in premature babies could be reversed or prevented with early intervention, suggests research carried out in sheep and published in Science Translational Medicine.

22 Jan 2013

Hospital-based home care can work for children with cancer

Hospital-based home care is a feasible alternative for children with cancer both regarding price and efficacy, show study findings.

22 Jan 2013

Pediatric CKD rates increase substantially in south of England

Research shows that the number of children with moderate-to-severe chronic kidney disease in the south of England rose significantly between 2005 and 2009.

15 Jan 2013

Monitor white blood cell count in pertussis infants

Researchers say that taking early and repeat white blood cell counts could help determine which children with pertussis are at highest risk for death.

14 Jan 2013

Glycan released by parasites might help treat metabolic disorders associated with obesity

On the list of undesirable medical conditions, a parasitic worm infection surely ranks fairly high. Although modern pharmaceuticals have made them less of a threat in some areas, these organisms are still a major cause of disease and disability throughout much of the developing world.

9 Jan 2013

Risk factors for retinopathy of prematurity identified

Birthweight and gestational age are risk factors for retinopathy of prematurity and should be considered when screening infants for the condition, a study by Turkish researchers shows.

9 Jan 2013

Moffitt Cancer Center initiates PV-10 Phase 1 study in melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, reports that the Moffitt Cancer Center has initiated a Phase 1 study to investigate potential immune biomarkers in both tumor tissue and peripheral blood after intralesional PV-10 injection of melanoma tumors.

9 Jan 2013

Trauma, infection link with stroke seen in children

Research shows that trauma and acute infection are significant risk factors for arterial ischemic stroke in children.

8 Jan 2013

Benefits of respiratory treatment for extremely premature infants persist

There are no significant differences in death or neurodevelopmental impairment between toddlers who underwent early continuous positive airway pressure or early surfactant administration as extremely premature infants, research shows.

7 Jan 2013

Researchers identify four new genetic regions associated with Behcet's disease

Researchers have identified four new regions on the human genome associated with Behcet's disease, a painful and potentially dangerous condition found predominantly in people with ancestors along the Silk Road.

7 Jan 2013

Biogen Idec files rFIXFc BLA with FDA for treatment of hemophilia B

Today Biogen Idec announced the company recently submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the marketing approval of recombinant factor IX Fc fusion protein (rFIXFc) for the treatment of hemophilia B.

7 Jan 2013

Racial disparities in hospital care of US children

The US healthcare system needs to undergo further reform if racial disparities in pediatric surgical care are to be addressed, report researchers.

3 Jan 2013

Pediatric caustic ingestion injuries ‘much lower than believed’

The public health burden associated with children swallowing caustic chemicals is less than widely believed, US researchers report in the Archives of Otolaryngology - Head and Neck Surgery.

2 Jan 2013

Rhinosinusitis without nasal polyps ‘predisposes to psoriasis’

People who suffer from chronic rhinosinusitis without nasal polyps have around twice the risk for psoriasis as the general population, a Taiwanese study has found.

28 Dec 2012

More children surviving heart attacks in hospital

Approximately three times more children survived in-hospital cardiac arrest in 2009 compared with 2000, indicate data from the Get With The Guidelines–Resuscitation registry.

24 Dec 2012

Continuous vancomycin optimizes neonate therapy

Researchers recommend that a patient-tailored dosing regimen is used routinely in neonates for continuous infusion therapy of the antibiotic, vancomycin.

24 Dec 2012

Extended steroid treatment fails to reduce pediatric nephrotic relapse

Study findings indicate that extending initial prednisolone treatment durations in patients with pediatric nephrotic syndrome from 3 to 6 months without increasing the overall dose does not reduce the number of relapses.

22 Dec 2012

French method successful for clubfoot

Researchers have demonstrated the efficacy of the “French” functional method for correcting congenital idiopathic clubfoot, with the majority of patients achieving a good result, often without surgery.

20 Dec 2012

Positive top-line results from Idera’s IMO-3100 Phase 2a trial on plaque psoriasis

Idera Pharmaceuticals today announced that 48% of patients with moderate-to-severe plaque psoriasis (12 of 25) treated with IMO-3100, a selective antagonist of Toll-like Receptors (TLRs) 7 and 9, demonstrated improvements in Psoriasis Area Severity Index (PASI) scores of 35% to 90% from baseline at the completion of a randomized, double-blind, placebo-controlled Phase 2a clinical trial of two dose levels of IMO-3100 administered for four weeks, with a four-week follow-up period.

20 Dec 2012